Patrick Schloemer

Also affiliated with Brigham and Women's Hospital, Harvard University, Climate Analytics, Bayer (Germany)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Finerenone in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Rationale and Design of the FINEARTS-HF Trial”.

Finerenone in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Rationale and Design of the FINEARTS-HF Trial

European Journal of Heart Failure(2024)10.1002/ejhf.3253

N/A

1.3DataRank · unranked

83 citations

Brian Claggett, Carolyn S.P. Lam, Bertram Pitt, Michele Senni, Sanjiv J. Shah +11 more

Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial

Nephrology Dialysis Transplantation(2024)10.1093/ndt/gfae132

N/A

0.661DataRank · unranked

81 citations

Rajiv Agarwal, George L. Bakris, David Z.I. Cherney, Carolyn S.P. Lam, Brendon L. Neuen +95 more

Interplay Between Heart Failure Events, New-Onset Diabetes, and Finerenone in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

Diabetes Care(2025)10.2337/dc25-2540

N/A

0DataRank · unranked

0 citations

Henri Lu, Brian Claggett, Akshay S. Desai, Pardeep S. Jhund, Alasdair D Henderson +13 more